Complementarity of Clinician Judgment and Evidence Based Models in Medical Decision Making: Antecedents, Prospects, and Challenges

Abstract

Early accounts of the development of modern medicine suggest that the clinical skills, scientific competence, and doctors' judgment were the main impetus for treatment decision, diagnosis, prognosis, therapy assessment, and medical progress. Yet, clinician judgment has its own critics and is sometimes harshly described as notoriously fallacious and an irrational and unfathomable black box with little transparency. With the rise of contemporary medical research, the reputation of clinician judgment has undergone significant reformation in the last century as its fallacious aspects are increasingly emphasized relative to the evidence based options. Within the last decade, however, medical forecasting literature has seen tremendous change and new understanding is emerging on best ways of sharing medical information to complement the evidence based medicine practices. This review revisits and highlights the core debate on clinical judgments and its interrelations with evidence based medicine. It outlines the key empirical results of clinician judgments relative to evidence based models and identifies its key strengths and prospects, the key limitations and conditions for the effective use of clinician judgment, and the extent to which it can be optimized and professionalized for medical use.

Chiropractic student choices in relation to indications, non-indications and contra-indications of continued care

“…Clinician judgment has been described as being notoriously fallible, irrational and difficult to comprehend [ 6 , 7 ]. As a result medical research has increasingly emphasized the need for evidence based medicine [ 8 ].…”

Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis

“…A number of approved treatment options currently exist for BRAFmutant patients with unresectable or metastatic melanoma (MM), and effective diagnosis tools are available for assessing BRAF mutational status [1][2][3]. Clinician judgment drives individualized treatment decisions based on characteristics of the patient and of the disease [4]. Since multiple options exist, it is essential that treatment decisions are informed by relevant and contemporary clinical research, including efficacy and safety data.…”

Clinical Decision Support for Worker Health: A Five-Site Qualitative Needs Assessment in Primary Care Settings

“…This is consistent with what others have found. 24,25 We also expected there to be interest in population health, since health care is moving toward valuebased care creating greater interest in data analytics to improve management of the health of their patient population. 26 We did not expect there would be such interest across all clinic sizes, however.…”